A 28-year-old woman from Odisha presents with multiple ill-defined hypopigmented and erythematous patches distributed symmetrically over her face, trunk, and extremities for 8 months. Slit-skin smear from an active lesion shows 4+ acid-fast bacilli. Lepromin test is negative. Nerve palpation reveals thickening of the ulnar and posterior tibial nerves bilaterally. She has no signs of lepra reaction. What is the most likely classification of her leprosy?

Explanation

## Clinical Diagnosis: Lepromatous Leprosy (LL) ### Key Features of This Case **Key Point:** The combination of multiple ill-defined symmetrically distributed hypopigmented/erythematous patches, high bacillary load (4+ AFB on slit-skin smear), strongly negative lepromin test, and bilateral nerve thickening is characteristic of lepromatous leprosy (LL). ### Ridley-Jopling Classification Spectrum | Feature | TT | BT | BB | BL | LL | |---------|----|----|----|----|----| | **Number of lesions** | 1–5 | 5–10 | 10–100 | >100 | Innumerable | | **Lesion definition** | Well-defined | Well-defined | Ill-defined | Ill-defined | Ill-defined | | **Symmetry** | Asymmetric | Asymmetric | Asymmetric | Relatively symmetric | Symmetric | | **Sensory loss** | Complete | Complete | Incomplete | Incomplete | Absent/minimal | | **Bacillary load (slit-skin)** | Negative | Negative/1+ | 1–4+ | 4–5+ | 5–6+ | | **Lepromin test** | Strongly +ve | +ve | Weakly +ve | Negative | Negative | | **Nerve involvement** | Early, severe | Moderate–severe | Moderate | Late, moderate | Bilateral, symmetric | **High-Yield:** LL is the lepromatous pole of the spectrum — absent cell-mediated immunity, high bacillary load, symmetrical lesion distribution, and negative lepromin test. The symmetrical distribution of lesions is a hallmark of LL. ### Why LL and Not BL? 1. **Symmetrical distribution** — The stem explicitly states lesions are distributed *symmetrically* over face, trunk, and extremities. Symmetry is a defining feature of LL, not BL. BL lesions tend to be asymmetric or only relatively symmetric. 2. **Negative lepromin test** — Both BL and LL are lepromin-negative, but in LL the test is consistently and strongly negative, reflecting complete absence of CMI. 3. **Bilateral nerve thickening** — Bilateral, symmetric nerve involvement (ulnar and posterior tibial bilaterally) is consistent with LL. 4. **4+ AFB** — While LL classically shows 5–6+, 4+ is within the range seen in LL, especially early or polar LL. BL typically shows 4–5+, but the symmetric clinical picture overrides this minor distinction. 5. **Ill-defined lesions** — Consistent with the lepromatous end of the spectrum (BL and LL); TT/BT show well-defined lesions. **Clinical Pearl:** The single most distinguishing feature between BL and LL in this vignette is **symmetry**. LL lesions are classically symmetrically distributed due to the predilection for cooler body areas and the absence of any cell-mediated immune response to contain bacillary spread. BL lesions, while numerous, tend to show some asymmetry. (Ref: Rook's Textbook of Dermatology; Park's Textbook of Preventive and Social Medicine, 26th ed.) ### Differential Reasoning | Feature in Stem | Points Toward | |-----------------|---------------| | Ill-defined patches | BL or LL | | Symmetric distribution | **LL** | | 4+ AFB | BL or LL | | Negative lepromin | BL or LL | | Bilateral nerve thickening | LL (symmetric) | | No lepra reaction | LL (Type 2 ENL less common at presentation) | **Mnemonic: "LL = Lepromatous Leprosy = Lots of bacilli, Low immunity, Looks Symmetric"** [cite:Park 26e Ch 8; Rook's Dermatology 9e]